Toxicities, intensive care management, and outcome of chimeric antigen receptor T cells in adults: an update
Chimeric antigen receptor T cells are a promising new immunotherapy for haematological malignancies. Six CAR-T cells products are currently available for adult patients with refractory or relapsed high-grade B...
Source: Critical Care - Category: Intensive Care Authors: Mathieu Bellal, Jolan Malherbe, Gandhi Damaj and Damien Du Cheyron Tags: Review Source Type: research